| Use of Breast Cancer Risk Reducing Medications |
Paul Pinsky |
National Institutes of Health |
PLCO |
Nov 19, 2024 |
PLCO-1749 |
| Use of deep learning to predict response of treatment for late stage lung cancer patients. |
Monika Mehta |
SGInnovate - Entrepreneur First |
PLCO |
Oct 3, 2019 |
PLCOI-531 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification |
Eric Li |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 10, 2021 |
PLCOI-876 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification in the Post-Surgical Setting |
Danielle Croucher |
Artera Inc. |
PLCO |
Oct 11, 2024 |
PLCOI-1703 |
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO |
Hormuzd Katki |
NCI |
PLCO |
Dec 8, 2021 |
PLCO-875 |
| Use of GWAS data to address the association between Human Leukocyte Antigen (HLA) and cancer |
Zhiwei Liu |
National Cancer Institute |
PLCO |
Jun 22, 2018 |
PLCO-375 |
| Use of head and neck cancer dataset |
Monika Khurana |
Independent |
PLCO |
Sep 20, 2017 |
PLCO-306 |
| Use of Machine Learning and Decision Classifiers in the Analysis of PLCO Ovarian Data |
Katherine Andriole |
Brigham and Women's Hospital, Harvard Medical School |
PLCO |
Mar 29, 2016 |
PLCO-201 |
| Use of neural networks in tissue abnormality detection |
Rafal Grzeszczuk |
AGH University of Science and Technology |
NLST |
Apr 11, 2017 |
NLST-299 |
| Use of PLCO data to evaluate the performance of cancer risk models |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Aug 22, 2022 |
PLCO-1025 |
| Use of PLCO data to evaluate the performance of cancer risk models (extramural) |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Jan 13, 2025 |
PLCO-1791 |
| USE OF PLCO IMAGING DATASET FOR MACHINE LEARNING PROJECTS |
Mannudeep Kalra |
Massachusetts General Hospital |
PLCO |
May 29, 2018 |
PLCO-366 |
| Use of prescriptive analytics in the desing of dynamic treatment regimes for breast cancer. |
Gustavo Mendoza Olguin |
Autonomous University of Puebla |
HIPB |
Jun 14, 2022 |
HIPB-9 |
| Use of previous-day recalls of physical activity and sedentary behavior in epidemiologic studies: results from four instruments |
Charles Matthews |
NCI / DCEG / Metabolic Epidemiology Branch |
IDATA |
Aug 21, 2018 |
IDATA-25 |
| Use of Radiomics and AI To Predict Malignancy in Indeterminate Lung Nodules |
Richard Lee |
The Royal Marsden Hospital |
NLST |
Nov 19, 2019 |
NLST-593 |
| Use of Regression Discontinuity to Measure the Effect of PSA Screening |
Jonathan Shoag |
None |
PLCO |
May 28, 2014 |
PLCO-90 |
| Use of the NLST CT and CXR Data to Better Understand Laten Tuberculosis and Risk of DIsease Progression |
William Stringer |
Harbor-UCLA Medical Center - LABIOMED |
NLST |
Feb 17, 2016 |
NLST-194 |
| Use of Tobacco Biomarkers in Lung Cancer Risk Assessment |
Christine Lambert |
University of Minnesota |
PLCO |
Jan 30, 2020 |
PLCO-563 |
| Using AI to predict cardiovascular disease |
yuankai wang |
University of Liverpool |
NLST |
Aug 8, 2023 |
NLST-1110 |
| Using Artificial Intelligence for the automatic interpretation of chest CT images |
Hugo Aerts |
Dana-Farber Cancer Institute, Inc. |
NLST |
Nov 14, 2017 |
NLST-374 |
